• Guideline Summary
  • NGC:009166
  • 1996 (revised 2012 Jun 26)

Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009101
  • 1996 (revised 2012 Jul 17)

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:011067
  • 2016 Sep 6

Screening for latent tuberculosis infection in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010798
  • 1996 (revised 2015 Oct)

Screening for iron deficiency anemia in young children: USPSTF recommendation statement.

  • Guideline Summary
  • NGC:010364
  • 1996 (revised 2014 Jun 3)

Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:011073
  • 2016 Jan

Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a Laboratory Medicine Best Practices systematic review and meta-analysis.

  • Guideline Summary
  • NGC:010605
  • 2009 (revised 2014)

Treatment of pressure ulcers. In: Prevention and treatment of pressure ulcers: clinical practice guideline.

  • Guideline Summary
  • NGC:009742
  • 2013 May

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

  • Guideline Summary
  • NGC:010057
  • 1996 (revised 2013 Nov 5)

Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.